Process View
A response to a stimulus that consists of a sequential series of modifications to a set of proteins where the product of one reaction acts catalytically in the following reaction. The magnitude of the response is typically amplified at each successive step in the cascade. Modifications typically include proteolysis or covalent modification, and may also include binding events.
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "protein activation cascade"
Name | Description | Probability | Func Analog Organism | |
---|---|---|---|---|
C1R | complement component 1, r subcomponent | 1.000 | Human | |
C1S | complement component 1, s subcomponent | 1.000 | Human | |
C3 | complement component 3 | 0.979 | ||
FGB | fibrinogen beta chain | 0.978 | Human | |
KRT15 | keratin 15 | 0.968 | ||
C1QA | complement component 1, q subcomponent, A chain | 0.956 | Mouse | |
SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 0.879 | ||
TP63 | tumor protein p63 | 0.863 | ||
SERPING1 | serpin peptidase inhibitor, clade G (C1 inhibitor), member 1 | 0.838 | ||
FGA | fibrinogen alpha chain | 0.817 | ||
C1QB | complement component 1, q subcomponent, B chain | 0.815 | ||
KRT19 | keratin 19 | 0.745 | ||
KRT17 | keratin 17 | 0.668 | ||
C1QC | complement component 1, q subcomponent, C chain | 0.579 | Zebrafish | |
TEK | TEK tyrosine kinase, endothelial | 0.537 | ||
ALB | albumin | 0.488 | ||
PPL | periplakin | 0.446 | ||
KRT14 | keratin 14 | 0.440 | ||
CFH | complement factor H | 0.439 | Mouse Rat | |
PLG | plasminogen | 0.392 | Human | |
KRT18 | keratin 18 | 0.387 | ||
FGG | fibrinogen gamma chain | 0.362 | ||
APOE | apolipoprotein E | 0.319 | ||
CFI | complement factor I | 0.313 | ||
A2M | alpha-2-macroglobulin | 0.312 | ||
MASP1 | mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor) | 0.300 | ||
DCN | decorin | 0.212 | ||
HRG | histidine-rich glycoprotein | 0.203 | ||
SERPINC1 | serpin peptidase inhibitor, clade C (antithrombin), member 1 | 0.181 | ||
DMBT1 | deleted in malignant brain tumors 1 | 0.177 | ||
F2 | coagulation factor II (thrombin) | 0.172 | ||
APCS | amyloid P component, serum | 0.163 | ||
MET | met proto-oncogene (hepatocyte growth factor receptor) | 0.160 | ||
TGM2 | transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) | 0.157 | ||
MASP2 | mannan-binding lectin serine peptidase 2 | 0.155 | ||
LPA | lipoprotein, Lp(a) | 0.151 | Human | |
KRT6B | keratin 6B | 0.139 | Human | |
APOH | apolipoprotein H (beta-2-glycoprotein I) | 0.127 | ||
C4B | complement component 4B (Chido blood group) | 0.124 | ||
C19orf50 | chromosome 19 open reading frame 50 | 0.114 | ||
RPS6KA6 | ribosomal protein S6 kinase, 90kDa, polypeptide 6 | 0.107 | ||
CFHR1 | complement factor H-related 1 | 0.103 | ||
ALOX12 | arachidonate 12-lipoxygenase | 0.103 | ||
PLAT | plasminogen activator, tissue | 0.102 | Human | |
KNG1 | kininogen 1 | 0.100 | ||
CYP2A6 | cytochrome P450, family 2, subfamily A, polypeptide 6 | 0.091 | ||
CYP1A2 | cytochrome P450, family 1, subfamily A, polypeptide 2 | 0.086 | ||
FCN2 | ficolin (collagen/fibrinogen domain containing lectin) 2 (hucolin) | 0.077 | ||
ANGPT2 | angiopoietin 2 | 0.071 | Human | |
HP | haptoglobin | 0.070 | ||
C8A | complement component 8, alpha polypeptide | 0.061 | ||
KRT6A | keratin 6A | 0.057 | Human | |
LECT2 | leukocyte cell-derived chemotaxin 2 | 0.057 | ||
ADH1B | alcohol dehydrogenase 1B (class I), beta polypeptide | 0.056 | ||
LBP | lipopolysaccharide binding protein | 0.054 | ||
C7 | complement component 7 | 0.054 | Human | |
C8B | complement component 8, beta polypeptide | 0.053 | Human | |
CFB | complement factor B | 0.053 | ||
DPT | dermatopontin | 0.052 | ||
RARRES2 | retinoic acid receptor responder (tazarotene induced) 2 | 0.050 | ||
CP | ceruloplasmin (ferroxidase) | 0.047 | ||
CYTB | cytochrome b | 0.047 | ||
KRT6C | keratin 6C | 0.043 | Human | |
SPP2 | secreted phosphoprotein 2, 24kDa | 0.040 | ||
C2 | complement component 2 | 0.038 | ||
APOA1 | apolipoprotein A-I | 0.037 | ||
TAT | tyrosine aminotransferase | 0.036 | ||
SAA4 | serum amyloid A4, constitutive | 0.036 | ||
NNMT | nicotinamide N-methyltransferase | 0.036 | ||
LRP1 | low density lipoprotein receptor-related protein 1 | 0.035 | ||
CFHR2 | complement factor H-related 2 | 0.035 | ||
HPX | hemopexin | 0.035 | ||
KRT2 | keratin 2 | 0.034 | Human | |
C6 | complement component 6 | 0.034 | Human Mouse | |
CTSB | cathepsin B | 0.033 | ||
HABP2 | hyaluronan binding protein 2 | 0.033 | Human | |
CXCL12 | chemokine (C-X-C motif) ligand 12 | 0.032 | ||
KRT9 | keratin 9 | 0.032 | ||
C10orf10 | chromosome 10 open reading frame 10 | 0.031 | ||
CYP4A11 | cytochrome P450, family 4, subfamily A, polypeptide 11 | 0.030 | ||
PPP2R2B | protein phosphatase 2, regulatory subunit B, beta | 0.030 | ||
CPN1 | carboxypeptidase N, polypeptide 1 | 0.030 | ||
C4BPB | complement component 4 binding protein, beta | 0.028 | ||
PTGDS | prostaglandin D2 synthase 21kDa (brain) | 0.028 | ||
MBL2 | mannose-binding lectin (protein C) 2, soluble | 0.027 | ||
SERPINF2 | serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 2 | 0.027 | Human | |
FETUB | fetuin B | 0.027 | ||
VTN | vitronectin | 0.026 | ||
CD164 | CD164 molecule, sialomucin | 0.026 | ||
GLYAT | glycine-N-acyltransferase | 0.026 | ||
EMILIN1 | elastin microfibril interfacer 1 | 0.026 | ||
IGF1 | insulin-like growth factor 1 (somatomedin C) | 0.025 | ||
CLU | clusterin | 0.024 | ||
TRIM29 | tripartite motif containing 29 | 0.023 | ||
ITIH1 | inter-alpha (globulin) inhibitor H1 | 0.023 | ||
RDH16 | retinol dehydrogenase 16 (all-trans) | 0.023 | ||
EMP1 | epithelial membrane protein 1 | 0.023 | ||
PHYH | phytanoyl-CoA 2-hydroxylase | 0.022 | ||
KRT4 | keratin 4 | 0.022 | Human | |
CCL16 | chemokine (C-C motif) ligand 16 | 0.021 | ||
APOF | apolipoprotein F | 0.021 | ||
COL6A2 | collagen, type VI, alpha 2 | 0.021 | ||
CCDC85B | coiled-coil domain containing 85B | 0.020 | ||
SPRR1A | small proline-rich protein 1A | 0.020 | ||
LIPC | lipase, hepatic | 0.020 | ||
PLTP | phospholipid transfer protein | 0.020 | ||
CFHR4 | complement factor H-related 4 | 0.020 | ||
KRT75 | keratin 75 | 0.020 | Human | |
C9 | complement component 9 | 0.019 | Human | |
F9 | coagulation factor IX | 0.019 | ||
PROZ | protein Z, vitamin K-dependent plasma glycoprotein | 0.019 | ||
SPARCL1 | SPARC-like 1 (hevin) | 0.019 | ||
KRT34 | keratin 34 | 0.018 | ||
CYP3A7 | cytochrome P450, family 3, subfamily A, polypeptide 7 | 0.018 | ||
AFM | afamin | 0.018 | ||
KLK10 | kallikrein-related peptidase 10 | 0.018 | ||
APOB | apolipoprotein B (including Ag(x) antigen) | 0.018 | ||
FMO3 | flavin containing monooxygenase 3 | 0.018 | ||
F10 | coagulation factor X | 0.017 | ||
FBN1 | fibrillin 1 | 0.017 | ||
CPB2 | carboxypeptidase B2 (plasma) | 0.017 | ||
PRELP | proline/arginine-rich end leucine-rich repeat protein | 0.017 | ||
IFITM2 | interferon induced transmembrane protein 2 (1-8D) | 0.017 | ||
KRT1 | keratin 1 | 0.017 | ||
F13B | coagulation factor XIII, B polypeptide | 0.017 | ||
SLC17A3 | solute carrier family 17 (sodium phosphate), member 3 | 0.017 | ||
PGCP | plasma glutamate carboxypeptidase | 0.017 | ||
APOC4 | apolipoprotein C-IV | 0.017 | ||
CA5A | carbonic anhydrase VA, mitochondrial | 0.016 | ||
ENPP2 | ectonucleotide pyrophosphatase/phosphodiesterase 2 | 0.016 | ||
F11 | coagulation factor XI | 0.016 | ||
S100A6 | S100 calcium binding protein A6 | 0.016 | ||
CPN2 | carboxypeptidase N, polypeptide 2 | 0.016 | ||
TMEM176A | transmembrane protein 176A | 0.016 | ||
ITIH2 | inter-alpha (globulin) inhibitor H2 | 0.016 | ||
IGFALS | insulin-like growth factor binding protein, acid labile subunit | 0.016 | ||
DNASE1L3 | deoxyribonuclease I-like 3 | 0.016 | ||
PLA2G2A | phospholipase A2, group IIA (platelets, synovial fluid) | 0.015 | ||
SFTPB | surfactant protein B | 0.015 | ||
TNXB | tenascin XB | 0.015 | ||
FBN3 | fibrillin 3 | 0.015 | ||
C4BPA | complement component 4 binding protein, alpha | 0.015 | ||
ITIH4 | inter-alpha (globulin) inhibitor H4 (plasma Kallikrein-sensitive glycoprotein) | 0.015 | ||
PAH | phenylalanine hydroxylase | 0.015 | ||
ORM1 | orosomucoid 1 | 0.014 | ||
AGXT | alanine-glyoxylate aminotransferase | 0.014 | ||
APOC2 | apolipoprotein C-II | 0.014 | ||
TEKT4 | tektin 4 | 0.014 | ||
PIK3AP1 | phosphoinositide-3-kinase adaptor protein 1 | 0.014 | ||
PCK1 | phosphoenolpyruvate carboxykinase 1 (soluble) | 0.014 | ||
CYP2C8 | cytochrome P450, family 2, subfamily C, polypeptide 8 | 0.014 | ||
KRT33B | keratin 33B | 0.014 | ||
FAM107A | family with sequence similarity 107, member A | 0.014 | ||
RABGEF1 | RAB guanine nucleotide exchange factor (GEF) 1 | 0.013 | ||
PLAUR | plasminogen activator, urokinase receptor | 0.013 | ||
HAL | histidine ammonia-lyase | 0.013 | ||
RARRES1 | retinoic acid receptor responder (tazarotene induced) 1 | 0.013 | ||
SERPINA5 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5 | 0.013 | ||
PKP1 | plakophilin 1 (ectodermal dysplasia/skin fragility syndrome) | 0.013 | ||
APOC1 | apolipoprotein C-I | 0.013 | ||
ARG1 | arginase, liver | 0.013 | ||
GGT5 | gamma-glutamyltransferase 5 | 0.013 | ||
CFD | complement factor D (adipsin) | 0.013 | ||
SFTPD | surfactant protein D | 0.013 | Human | |
CETP | cholesteryl ester transfer protein, plasma | 0.013 | ||
PLAU | plasminogen activator, urokinase | 0.012 | Human | |
HSD11B1 | hydroxysteroid (11-beta) dehydrogenase 1 | 0.012 | ||
SLCO2B1 | solute carrier organic anion transporter family, member 2B1 | 0.012 | ||
COLEC10 | collectin sub-family member 10 (C-type lectin) | 0.012 | Human | |
PLA1A | phospholipase A1 member A | 0.012 | ||
ISLR | immunoglobulin superfamily containing leucine-rich repeat | 0.012 | ||
PARP4 | poly (ADP-ribose) polymerase family, member 4 | 0.012 | ||
HAO1 | hydroxyacid oxidase (glycolate oxidase) 1 | 0.012 | ||
MFAP4 | microfibrillar-associated protein 4 | 0.012 | Human | |
SLC10A1 | solute carrier family 10 (sodium/bile acid cotransporter family), member 1 | 0.012 | ||
SERPINA6 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 6 | 0.012 | ||
ZNF431 | zinc finger protein 431 | 0.012 | ||
ECM2 | extracellular matrix protein 2, female organ and adipocyte specific | 0.011 | ||
NR1H4 | nuclear receptor subfamily 1, group H, member 4 | 0.011 | ||
TTR | transthyretin | 0.011 | ||
KRT16 | keratin 16 | 0.011 | ||
SLURP1 | secreted LY6/PLAUR domain containing 1 | 0.011 | ||
GCGR | glucagon receptor | 0.011 | ||
AHSG | alpha-2-HS-glycoprotein | 0.011 | ||
SERPINA3 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3 | 0.011 | ||
DOCK7 | dedicator of cytokinesis 7 | 0.011 | ||
LCAT | lecithin-cholesterol acyltransferase | 0.011 | ||
CSF1R | colony stimulating factor 1 receptor | 0.011 | ||
CLIC2 | chloride intracellular channel 2 | 0.011 | ||
AEBP1 | AE binding protein 1 | 0.011 | ||
OLFML3 | olfactomedin-like 3 | 0.011 | ||
A1BG | alpha-1-B glycoprotein | 0.011 | ||
MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 0.011 | ||
APOD | apolipoprotein D | 0.011 | ||
CCL2 | chemokine (C-C motif) ligand 2 | 0.011 | ||
CD163 | CD163 molecule | 0.010 | ||
S100A2 | S100 calcium binding protein A2 | 0.010 | ||
VCAM1 | vascular cell adhesion molecule 1 | 0.010 | ||
CYP8B1 | cytochrome P450, family 8, subfamily B, polypeptide 1 | 0.010 | ||
IGFBP4 | insulin-like growth factor binding protein 4 | 0.010 | ||
SRPX | sushi-repeat containing protein, X-linked | 0.010 | ||
C8G | complement component 8, gamma polypeptide | 0.010 | ||
ABCA6 | ATP-binding cassette, sub-family A (ABC1), member 6 | 0.010 | ||
SERPIND1 | serpin peptidase inhibitor, clade D (heparin cofactor), member 1 | 0.010 | ||
LY6G6F | lymphocyte antigen 6 complex, locus G6F | 0.010 |